A detailed history of Central Trust CO transactions in Illumina, Inc. stock. As of the latest transaction made, Central Trust CO holds 51 shares of ILMN stock, worth $7,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 46 10.87%
Holding current value
$7,147
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$105.28 - $135.9 $526 - $679
5 Added 10.87%
51 $6,000
Q4 2023

Jan 24, 2024

SELL
$92.79 - $142.53 $18,929 - $29,076
-204 Reduced 81.6%
46 $6,000
Q4 2022

Jan 26, 2023

SELL
$187.24 - $242.74 $5,617 - $7,282
-30 Reduced 10.71%
250 $0
Q3 2022

Nov 17, 2022

SELL
$177.23 - $227.44 $4,607 - $5,913
-26 Reduced 8.5%
280 $54,000
Q2 2022

Aug 09, 2022

SELL
$181.58 - $368.0 $12,710 - $25,760
-70 Reduced 18.62%
306 $57,000
Q1 2022

May 03, 2022

SELL
$303.87 - $423.8 $27,652 - $38,565
-91 Reduced 19.49%
376 $131,000
Q4 2021

Feb 08, 2022

SELL
$347.28 - $421.83 $10,765 - $13,076
-31 Reduced 6.22%
467 $177,000
Q3 2021

Oct 19, 2021

BUY
$405.61 - $524.84 $121,683 - $157,452
300 Added 151.52%
498 $201,000
Q4 2020

Jan 29, 2021

SELL
$292.7 - $370.96 $36,587 - $46,370
-125 Reduced 38.7%
198 $73,000
Q3 2020

Oct 22, 2020

BUY
$268.51 - $400.74 $10,203 - $15,228
38 Added 13.33%
323 $99,000
Q3 2019

Oct 28, 2019

SELL
$266.84 - $378.23 $189,456 - $268,543
-710 Reduced 71.36%
285 $87,000
Q2 2019

Jul 12, 2019

BUY
$300.59 - $368.15 $213,418 - $261,386
710 Added 249.12%
995 $0
Q4 2018

Jan 08, 2019

BUY
$272.46 - $366.54 $72,201 - $97,133
265 Added 1325.0%
285 $85,000
Q3 2018

Oct 04, 2018

BUY
$279.04 - $367.06 $2,790 - $3,670
10 Added 100.0%
20 $0
Q2 2018

Jul 09, 2018

SELL
$228.17 - $292.07 $1,140 - $1,460
-5 Reduced 33.33%
10 $0
Q3 2017

Oct 17, 2017

BUY
$172.3 - $213.93 $2,584 - $3,208
15
15 $0

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.